(Q28543626)

English

A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load

scientific article

In more languages

Statements

scholarly article

0 references

A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral load (English)

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Hugues Charest

0 references

11

object named as

Mark A Wainberg

0 references

12

object named as

Michel Roger

0 references

Cécile Tremblay

13

object named as

Cécile Tremblay

0 references

6

object named as

Bluma Brenner

0 references

8

object named as

Daniela Moisi

0 references

10

object named as

Jean-Guy Baril

0 references

7

object named as

Isabelle Hardy

0 references

author name string

Florence Doualla-Bell

2

0 references

Régis Cantin

3

0 references

Donald G Murphy

4

0 references

Linda Lemieux

5

0 references

Ernest Lo

9

0 references

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

10

0 references

e109420

0 references

copyright license

Creative Commons Attribution 4.0 International

8 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

19 March 2017

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

7 April 2017

Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Treatment to prevent transmission of HIV-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Transmission networks of drug resistance acquired in primary/early stage HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

High rates of forward transmission events after acute/early HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

29 September 2017

Transmission of drug-resistant HIV-1 is stabilizing in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

3 June 2018

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

3 June 2018

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2003 to 2008 in Japan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Reduced emergence of the M184V/I resistance mutation when antiretroviral-naïve subjects use emtricitabine versus lamivudine in regimens composed of two NRTIs plus the NNRTI efavirenz.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0109420

21 January 2018

Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

27 November 2018

Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

27 November 2018

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4190276

27 November 2018

Identifiers

10.1371/JOURNAL.PONE.0109420

0 references

2014PLoSO...9j9420C

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28543626&oldid=1985028454"